Vol. 30 (1) 2023
Evaluation of circulating miR-16-5p and miR-223-5p in association with musculoskeletal ultrasonography seven-joint score in the assessment of rheumatoid arthritis activity The Egyptian Journal of Immunology Volume 30 (1), January, 2023 Pages: 20–30....
Vol. 30 (1) 2023
Evaluation of diagnostic performance of a rapid antigen test in diagnosing COVID-19 The Egyptian Journal of Immunology Volume 30 (1), January, 2023 Pages: 14–19. www.Ejimmunology.org https://doi.org/10.55133/eji.300102 Eman R. Badawy, Azza M. Ezz El-Din and Randa A....
Vol. 30 (1) 2023
Assessment of diagnostic and prognostic laboratory biomarkers in severe COVID-19 patients admitted to intensive care unit The Egyptian Journal of Immunology Volume 30 (1), January, 2023 Pages: 01–13. www.Ejimmunology.org https://doi.org/10.55133/eji.300101 Mohamed...
Vol. 29 (4) 2022
Antibodies against a mutated citrullinated vimentin in patients with rheumatoid arthritis The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 184–194. www.Ejimmunology.org https://doi.org/10.55133/eji.290418 Dalia A. Nigm1, Hanan H. Abdel-Lateef1,...
Vol. 29 (4) 2022
Role of IL-17A in enhancing liver fibrosis induced by TGF-β1 and IL-13 in Schistosoma mansoni infected mice The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 174–183. www.Ejimmunology.org https://doi.org/10.55133/eji.290417 Mohamed H. Abd Allah1,...
Vol. 29 (4) 2022
sVCAM-1, and TGFβ1 in chronic phase, chronic myeloid leukemia patients treated with tyrosine kinase inhibitors The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 163–173. www.Ejimmunology.org https://doi.org/10.55133/eji.290416 Muhamad R. Abdel...